🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — August 04, 2026

The Consumer Staples sector shows a bifurcated earnings picture: ADM delivered a standout quarter with EPS up 98% YoY and raised guidance, while Kimberly-Clark faces a China-driven headwind that has pressured organic sales and net income. Insider activity is predominantly neutral (tax withholdings and routine awards), with one notable 10b5-1 sale at Walmart. Capital allocation remains stable with no major buyback or dividend changes disclosed. Key themes include margin expansion (ADM, Kimberly-Clark adjusted gross margin up 190 bps), the impact of geopolitical/supply chain events (ADM's Barcarena terminal, Kimberly-Clark's China issue), and a cautious outlook for organic growth in the sector. The most actionable signals are ADM's upward guidance revision and Kimberly-Clark's China-related risk, which investors should monitor closely.

7 high priority 2 medium 9 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 04, 2026

The S&P 500 Industrials sector is showing robust growth, led by Caterpillar's record Q2 with sales up 24% YoY and EPS surging 68%, and Cummins' record revenues up 9% with raised guidance. However, margin compression is a recurring theme, with Emerson's Safety & Productivity segment down 230 bps and Cummins' EBITDA margin down 90 bps, partly due to higher incentive compensation and restructuring costs. Insider activity is notable: General Dynamics' CEO and EVP sold significant shares (~$55M combined) after exercising options, while Honeywell executives received substantial RSU awards, signaling confidence. Capital allocation remains shareholder-friendly, with Caterpillar deploying $2.2B in buybacks and dividends. Key risks include rising credit losses at Caterpillar Financial, increased tax rates, and foreign currency translation losses at Emerson. Forward-looking guidance is positive, with Cummins raising revenue and EBITDA targets, and Emerson raising EPS and FCF outlook, suggesting continued optimism in data center and infrastructure demand.

19 high priority 6 medium 25 total filings
· daily

US Material Events SEC 8-K Filings — August 04, 2026

The 50 filings from August 4, 2026, reveal a market bifurcated between aggressive capital deployment (M&A, debt refinancing, and spin-offs) and operational distress (workforce reductions, goodwill impairments, and CEO departures). A clear theme is the 'growth vs. profitability' trade-off, with several companies like Marqeta and Angi reporting strong top-line or strategic metrics but issuing cautious forward guidance or taking massive non-cash charges. The period-over-period data shows a mixed picture: revenue growth is present in pockets (Hillman Solutions +9.8% YoY, Better Home +28% YoY), but margin compression and net losses are widespread, particularly in the transportation and consumer services sectors. The most critical developments include the $102.50/share acquisition of Lantheus by Curium, the massive 84.6% dilution for existing shareholders in the Wellgistics/DataMEDS AI deal, and the strategic pivot of Kustom Entertainment. Insider activity is limited but notable, with the FTFT offering by a controlling shareholder and the $2.5M Meteora investment in Fusemachines signaling confidence. The forward-looking data is a key differentiator, with Hillman Solutions raising guidance while Marqeta and Lumen signal a sharp deceleration, creating a clear catalyst calendar for investors.

50 high priority 50 total filings
· daily

Insider Trading Pulse — August 04, 2026

The daily digest of insider transactions reveals a predominantly neutral sentiment with routine director and officer equity awards, but several notable insider sales and disposals warrant attention. Key developments include a massive $96.4M sale by a 10% owner in Jersey Mike's Subs, a $3.85M sale by a 10% owner in Anteris Technologies, and insider sales totaling $662K across Quad/Graphics directors and executives. On the acquisition side, a CEO of Solana Co received a substantial 923,000 stock option grant, signaling strong alignment. The period-over-period data shows consistent director compensation patterns across companies like Netflix and Jasper Therapeutics, while insider activity in Chinese ADRs (PDD Holdings, TAL Education) suggests mixed sentiment. Overall, the digest highlights potential overvaluation concerns in consumer and healthcare sectors, while routine equity awards indicate standard governance practices.

39 high priority 11 medium 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 04, 2026

The 19 filings from Dow 30 constituents reveal a bifurcated earnings season: industrial and resource-linked names like Caterpillar and Honeywell show robust growth and strong capital returns, while consumer-facing giants McDonald's, Procter & Gamble, and Walmart signal slowing demand and margin pressure. Healthcare leaders Merck and Amgen face growth challenges in legacy products but are investing heavily in M&A and new launches. Insider activity is dominated by routine, non-suggestive equity compensation transactions at Honeywell, with one notable sale at Walmart under a 10b5-1 plan. Capital allocation remains shareholder-friendly, with Caterpillar repurchasing $1.5B and paying $0.7B in dividends in Q2 2026, while Amgen paused buybacks. Key forward-looking catalysts include McDonald's leadership change to address U.S. underperformance, Merck's Terns acquisition integration, and Amgen's full-year repurchase cap. Overall, the theme is 'growth with caution'—strong operational performance in industrials contrasts with consumer softness and healthcare transition costs.

14 high priority 5 medium 19 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 04, 2026

The two filings in this stream present a stark contrast in corporate distress trajectories. Bed Bath & Beyond (BBBY) shows a classic turnaround story with its second consecutive quarter of revenue growth (+28% YoY) and a 47% surge in active customers, yet its net loss widened to -$39M from -$19M YoY, and Adjusted EBITDA deteriorated to -$12M, signaling that growth is not yet profitable. The company's transformation into Neighborhood Intelligence and planned Nasdaq listing under ticker NXH suggests a strategic pivot, but the widening losses and ballooning Technology & G&A expenses (+$45M YoY) raise concerns about cost control. Meanwhile, VSEE Health faces an imminent delisting crisis, with a Nasdaq Staff Determination triggered by a bid price of $0.10 or less for ten consecutive days, leading to a trading suspension on August 6, 2026. The company's appeal window is open but offers no stay of execution, making this a high-probability delisting event. The period-over-period data shows no revenue or margin improvements for VSEE, and the lack of any forward-looking guidance or insider activity underscores a dire liquidity situation. The overarching theme is that top-line recovery alone does not equate to financial health, and the market is punishing companies with unsustainable cash burns and low stock prices.

2 high priority 2 total filings
· daily

Global High-Priority Regulatory Events — August 04, 2026

The August 4, 2026 filing batch reveals a market bifurcated between aggressive strategic repositioning and persistent distress. Key themes include a wave of private credit BDC tender offers (5 filings) signaling a sector-wide liquidity management trend, significant M&A activity in India (8 deals) across auto components, real estate, and e-commerce, and several high-profile delistings including Electronic Arts' $210/share take-private and SOLAI Ltd's failure to meet listing standards. Financial performance is mixed: Bed Bath & Beyond shows a remarkable revenue turnaround (+28% YoY) but widening losses, while Nykaa and Worth Peripherals deliver strong profit growth. Distress signals are prominent with Quadrant Televentures' insolvency extension, VSEE Health's imminent delisting, and DuPont's sharp swing to a net loss. Insider activity is limited, but capital allocation is active with multiple buybacks and tender offers. The overall picture is one of active portfolio reshaping, with investors rotating capital toward growth and away from structurally challenged assets.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 04, 2026

Today's filings reveal a market bifurcated between strong operational performers and those facing significant headwinds. Palantir, ADM, and Quanta Services posted exceptional growth, with Palantir's revenue surging 92.8% YoY and ADM's adjusted EPS nearly doubling. However, a wave of mixed results and guidance cuts from companies like Smith & Nephew, Ingredion, and Toyota highlights persistent margin pressure and demand uncertainty. The most critical development is the $5.3 billion acquisition of Lantheus Holdings by Curium, which, alongside the pending Prologis/SEGRO deal and Abra Financial's SPAC merger, signals robust M&A activity. Insider activity is notably absent from most filings, but capital allocation trends are clear: aggressive buybacks from Gartner and BBVA contrast with a major debt refinancing by Southern Co. The biotech sector presents a stark dichotomy, with IDEAYA's positive Phase 3 results juxtaposed against Lipocine's failed trial and Lisata's drastic workforce reduction. Overall, the digest points to a 'show-me' market where execution is rewarded and guidance is being scrutinized.

17 high priority 33 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 04, 2026

The S&P 500 Consumer Discretionary sector is showing a clear divergence between resilient travel demand and a softening quick-service restaurant (QSR) environment. Booking Holdings reported a 118% surge in net income and 8% revenue growth, though forward guidance for room night growth points to a deceleration. In contrast, McDonald's U.S. comparable sales growth slowed sharply to +0.8% from +2.5% a year ago, prompting a leadership change. Carvana saw a significant insider buying event from a director ($1.54M) alongside multiple C-suite sales under 10b5-1 plans, creating a mixed signal on management conviction. Capital allocation trends are aggressive: Booking Holdings is deepening its stockholders' deficit through buybacks, while Aptiv used a $1.9B spin-off dividend to aggressively deleverage. The period-over-period data reveals margin expansion at Aptiv (+160 bps) and strong earnings growth at Booking, but the overall consumer discretionary landscape is cautious, with negative guest counts at McDonald's and mixed insider activity across the portfolio.

16 high priority 4 medium 20 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 04, 2026

The S&P 500 Healthcare sector is exhibiting a clear bifurcation in Q2 2026: top-tier innovators like Vertex and Amgen are delivering double-digit revenue growth (12.5% and 10% YoY, respectively) and expanding margins, while legacy pharma giants like Pfizer and Merck face earnings headwinds from large acquisition-related charges and asset impairments. A wave of aggressive M&A, particularly in biotech (Gilead's $11.2B in acquired IPR&D, Merck's Terns acquisition), is driving significant GAAP losses and depleting cash reserves, signaling a high-stakes bet on pipeline replenishment. Capital allocation patterns are diverging sharply, with Vertex and IDEXX aggressively buying back shares (combined ~$1.5B in H1 2026), while Amgen and Pfizer pause repurchases to fund deals. Insider activity is mixed but notable: Gilead's CEO sold ~$1.96M under a 10b5-1 plan, while Medtronic's top brass received substantial equity awards, suggesting confidence in long-term strategy. The most critical development is the sector-wide margin pressure from rising SG&A (Vertex +37% YoY) and R&D investment, even as top-line growth remains resilient.

30 high priority 6 medium 36 total filings
· daily

US Earnings Financial Results SEC Filings — August 04, 2026

The Q2 2026 earnings season reveals a bifurcated market where top-line growth is often masking significant margin compression and earnings quality deterioration. Of the 50 filings analyzed, 12 companies reported revenue growth exceeding 20% YoY, yet 8 of those saw net income decline or losses widen, driven by soaring operating expenses, restructuring charges, and inventory build-ups. The most prominent theme is a 'growth at any cost' dynamic, particularly in tech-enabled and industrial sectors, where companies like Palantir (+92.8% revenue) and Paymentus (+28.8%) are exceptions, while others like Voyager Technologies (+15.5% revenue but -45.7% gross profit) and Shoals Technologies (+47.4% revenue but -12.4% net income) are burning cash to grow. The energy sector is a standout positive, with EOG Resources more than doubling net income on surging crude revenues. A critical portfolio-level pattern is the aggressive use of debt and equity financing to fund operations and acquisitions, with Hut 8 raising $7.7B in new debt and Kratos raising $1.35B in equity, signaling a potential liquidity crunch if growth stalls. Insider activity is notably absent from the enriched data, but capital allocation trends show a clear preference for share repurchases over dividends, with Credit Acceptance and Matson aggressively buying back stock, while Pfizer and others are cutting costs. The key takeaway for investors is to look beyond revenue growth and scrutinize cash flow, operating leverage, and the sustainability of capital structures.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 04, 2026

This digest of 9 proxy filings reveals a bifurcated landscape: capital-intensive firms like AAR Corp are executing aggressive growth strategies (record $3.3B sales, 4 acquisitions) but facing cash flow strain and high debt, while micro-cap entities like Salarius Pharmaceuticals and FREVS are in existential transitions—one relying on milestone-driven warrant exercises to fund clinical trials, the other liquidating entirely. A notable theme is the prevalence of 'mixed' sentiment in filings with material financial stakes (AAR, Salarius), reflecting tension between operational momentum and balance sheet fragility. Insider activity is sparse across the set, but the absence of selling in AAR (despite a 29% EPS beat) is a modest positive signal. The most actionable catalysts are Salarius's September 27 special meeting (potential $17.5M cash infusion) and FREVS's liquidation timeline, which creates a defined path to capital return. Governance patterns are standard, with no activist campaigns or shareholder revolts flagged, though RENN Fund's leadership void from Murray Stahl's passing warrants monitoring for strategic drift.

9 high priority 9 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 04, 2026

The IPO pipeline for August 4, 2026, is dominated by a single new SPAC registration, Luminous Acquisition, which seeks to raise capital for a blank-check business combination, reflecting continued but measured SPAC activity. The filing shows a mixed sentiment due to the inherent risks of SPAC structures, including warrant redemption terms and expiration of rights if no deal is completed. DuPont de Nemours, while filing an S-4 for a debt exchange offer, is not a new IPO but provides critical context on capital markets activity and corporate financial health, with a sharp YoY swing from net income of $703 million in 2024 to a net loss of $779 million in 2025. The DuPont filing also highlights a 1-for-3 reverse stock split, signaling potential efforts to maintain listing standards or improve share price perception. No insider trading activity or forward-looking guidance was provided in these filings, limiting trend analysis but underscoring the importance of monitoring deal timelines and financial performance. The overall pipeline shows a mix of speculative SPAC issuance and established corporate debt restructuring, with no traditional operating company IPOs in this batch.

2 high priority 2 total filings
· daily

US SEC Trading Suspension Halt Orders — August 04, 2026

The USA Trading Suspensions stream for August 4, 2026, reveals two contrasting events: Bed Bath & Beyond is undergoing a transformative turnaround with strong revenue growth and a planned Nasdaq listing, while VSEE Health faces an imminent delisting due to a critically low stock price. Period-over-period data shows Bed Bath & Beyond's revenue surged 28% YoY and orders grew 117%, but losses widened, indicating a high-cost recovery phase. VSEE Health's delisting is a terminal regulatory event with no appeal stay, highlighting severe financial distress. The key theme is the divergence between a company executing a strategic pivot and one failing to meet basic listing standards, both generating significant trading suspension risks. Insider activity and forward-looking data are limited in these filings, but the operational metrics and regulatory timelines provide actionable intelligence for investors monitoring suspension events.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — August 04, 2026

This digest covers 44 filings related to USA executive and director changes, with a significant concentration of CEO transitions and strategic leadership shifts. A key theme is the high number of CEO departures (at least 8) across diverse sectors, including Fuel Tech, TELA Bio, Better Home & Finance, 3D Systems, Matthews International, Dave & Buster's, and Steel Dynamics, often part of planned successions. The filings also reveal a mix of financial health signals: while some companies like Marqeta and PAMT CORP show improving profitability, others like Angi Inc. and Lumen Technologies report declining revenues and significant impairments. A notable pattern is the use of inducement equity awards for new executives, indicating a competitive talent market. The data also highlights several risk factors, including a major workforce reduction at Lisata Therapeutics, a sharp deceleration in guidance at Marqeta, and a pending CEO vacancy at 3D Systems, which create actionable investment signals.

44 high priority 44 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 04, 2026

The 44 filings for August 4, 2026, reveal a significant wave of leadership transitions across the US market, with 30+ companies reporting CEO, CFO, or board changes. The most critical developments are concentrated in the small-to-mid-cap healthcare and technology sectors, where several companies are undergoing forced or strategic restructurings. Notable period-over-period trends from the earnings reports embedded in these filings show a mixed picture: while Marqeta and Better Home & Finance posted strong revenue growth (32% and 38% YoY respectively), others like Lumen Technologies (-9% YoY) and Angi Inc. (-11% YoY) are contracting. A clear pattern of insider departures amid financial distress is emerging, with Lisata Therapeutics (72% workforce reduction) and Better Home (founder CEO ousted, ongoing losses) signaling deep operational challenges. The market is also seeing a wave of planned CEO successions at large caps (Steel Dynamics, McDonald's, Johnson & Johnson), which are generally viewed as neutral-to-positive due to orderly transitions. The most actionable intelligence lies in the diverging fortunes of companies like Marqeta (strong growth but sharp guidance deceleration) versus the distressed restructurings at Lisata and Better Home, where insider moves and forward-looking statements point to significant downside risk.

44 high priority 44 total filings
· daily

USA Insider Trading Pulse — August 04, 2026

The August 4, 2026, insider trading pulse reveals a market characterized by significant insider selling, particularly by major shareholders and C-suite executives, signaling caution in several sectors. Notable large-scale disposals include a $96.4M sale by Abu Dhabi Investment Authority in Jersey Mike's Subs and a $3.85M sale by L1 Capital in Anteris Technologies, both bearish signals for their respective companies. Conversely, insider buying is concentrated in financials and select industrials, with a TSMC VP making a $73K purchase and a director at Alliance Resource Partners buying $78K, suggesting selective value opportunities. The data shows a clear divergence: while routine director awards and option exercises are common, the material, open-market selling by informed parties outweighs buying, creating a cautious overall tone. Key themes include insider profit-taking in high-growth tech and consumer names, and a rotation into perceived value in regional banks and energy. The lack of forward-looking guidance changes in the filings limits catalyst visibility, but the insider activity itself serves as a powerful, real-time signal for portfolio managers to scrutinize positions in companies with heavy insider selling.

41 high priority 9 medium 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 04, 2026

The US M&A and takeover landscape during this period is characterized by a wave of SPAC activity, strategic corporate divestitures, and a landmark take-private transaction. Key themes include SPACs extending deadlines (Pyrophyte, Valuence) and financing mergers (Columbus, Calisa), alongside significant portfolio reshaping by operating companies (Resideo, Griffon, Digital Ally/Cycurion). The most material event is Electronic Arts' $210/share acquisition by a consortium led by PIF and Silver Lake, marking a major delisting and a shift in gaming industry ownership. Period-over-period data reveals a focus on deleveraging (Resideo's $900M debt repayment, Griffon's $181M cash infusion) and strategic pivots to higher-growth or core businesses (Digital Ally's exit from video solutions, Resideo's spin-off of ADI). Insider activity is limited, but sponsor participation in Calisa's subscription agreement signals confidence. Overall, the period reflects a mix of cautious extension strategies in the SPAC market and decisive value-unlocking actions by established companies.

14 high priority 14 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 04, 2026

Overnight filings reveal a bifurcated market environment where industrial and commodity-linked companies are delivering robust growth, while several healthcare and tech names face headwinds. Palantir Technologies reported staggering 92.8% YoY revenue growth and raised guidance, while ADM's adjusted EPS surged 98% YoY, leading to upward revisions in full-year forecasts. Conversely, Ingredion and Smith & Nephew both cut guidance due to operational disruptions and product headwinds, respectively. Insider activity was mixed: a coordinated insider buying spree at SPAC East West Ave Acquisition Corp. contrasts with significant stock sales at Snowflake and New Oriental Education. Capital allocation trends show a strong preference for share repurchases, with DuPont, Grab, and Equinor announcing or executing buybacks. A notable pattern is the divergence between GAAP and adjusted earnings, with companies like Qnity Electronics and Eve Holding showing improved operational metrics but wider GAAP losses due to non-recurring items.

33 high priority 17 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 03, 2026

The August 3, 2026 SEC filings for the S&P 500 Technology sector reveal a stark divergence between high-growth AI-native companies and mature hardware/software firms. Palantir Technologies reported exceptional Q2 2026 results, with total revenue surging 93% YoY and U.S. commercial revenue skyrocketing 149% YoY, significantly outperforming the sector. The company raised its full-year guidance, signaling sustained momentum. In contrast, KLA Corporation, a semiconductor equipment maker, saw multiple top executives (CEO, CFO, SVP) engage in routine tax-withholding stock sales, indicating no insider conviction but no panic either. Datadog and CrowdStrike saw significant insider selling by directors and CEOs, respectively, under 10b5-1 plans, which may signal profit-taking at elevated valuations. Autodesk completed its acquisition of MaintainX, expanding its asset management capabilities. The overarching theme is a 'two-speed' tech market: AI/software leaders are accelerating, while legacy hardware and cybersecurity firms show insider caution. Portfolio-level trends highlight strong revenue growth in AI-adjacent software, but insider selling patterns suggest skepticism about sustaining current valuations.

12 high priority 1 medium 13 total filings